En
Register Log in
  1. Main
  2. Conference
  3. Fundamental and applied research for key propriety...
  4. Otsenka mutatsionnogo statusa genov BRAF, NRAS i C...

Otsenka mutatsionnogo statusa genov BRAF, NRAS i CDKN2A v dobrokachestvennykh obrazovaniiakh kozhi

Proceeding
DOI: 10.31483/r-106992
Open Access
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Creative commons logo
Published in:
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Authors:
Anastasiia V. Khambikova 1 , Anastasiia K. Koroleva 1 , Atabeg B. Achilov 1 , Elena I. Antonova 1
Work direction:
Молекулярная биология, генетика, микробиология
Pages:
66-73
Received: 26 May 2023

Rating:
Article accesses:
798
Published in:
РИНЦ
1 Nauchno-issledovatel'skii tsentr fundamental'nykh i prikladnykh problem bioekologii i biotekhnologii FGBOU VO "Ul'ianovskii gosudarstvennyi pedagogicheskii universitet im. I.N. Ul'ianova"
For citation:
Khambikova A. V., Koroleva A. K., Achilov A. B., & Antonova E. I. (2023). Otsenka mutatsionnogo statusa genov BRAF, NRAS i CDKN2A v dobrokachestvennykh obrazovaniiakh kozhi. Fundamental and applied research for key propriety areas of bioecology and biotechnology, 66-73. Чебоксары: PH "Sreda". https://doi.org/10.31483/r-106992

Abstract

Невусы относят к доброкачественным меланоцитарным новообразованиям с неопределённым биологическим потенциалом. Между генами, ассоциированными с невусом и меланомой, а также между фенотипическими и клеточными особенностями невусов и меланомы проявляются выраженные корреляции. В связи с этим для эффективного мониторинга и ранней диагностики меланомы необходим одномоментный мультиплексный скрининг по всем основным драйверным мутациям. В статье отражены результаты молекулярно-генетических исследований мутаций генов BRAF, NRAS и CDKN2A пациентов с гистологическим заключением внутридермальный невус кожи.

References

  1. 1. Соколикова В.Б. Отличительные морфологические и молекулярно-генетические особенности меланомы кожи и диспластических невусов / В.Б. Соколикова, Ю.В. Можинская, Е.М. Непомнящая [и др.] // Молодой ученый. – 2016. – №15.2 (119.2). – С. 5–37.
  2. 2. Bastian B.C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia // Annual review of the Pathology. – 2014. – V. 9:239 – Р. 71.
  3. 3. Clark W.H. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma / W.H. Clark, D.E. Elder, D. Guerry, M.N. Epstein, M.H Greene, M. Van Horn // Human Pathology. – 1984. – V. 15 (12). – P. 1147–1165.
  4. 4. Damsky W.E. Melanocytic nevi and melanoma: unraveling a complex relationship / WE Damsky, M Bosenberg // Oncogene. – 2017. – 36 (42). – P. 5771–16. – DOI 10.1038/onc.2017.189. – EDN YKCYLL
  5. 5. Gray-Schopfer V.C. Cellular senescence in naevi and immortalisation in melanoma: a role for p16? / V.C. Gray-Schopfer, H. Chong, J. Chow, T. Moss, Z.A. Abdel-Malek, R. Marais, D. Wynford-Thomas, D.C. Bennett [et al.] // British journal of cancer. – 2006. – 95 (4). – P. 496–505. – DOI 10.1038/sj.bjc.6603283. – EDN KYNMOF
  6. 6. Haenssle H.A. Association of patient risk factors and frequency of nevus-associated cutaneous melanomas / H.A. Haenssle, A. Mograby, A. Ngassa [et al.] // JAMA Dermatology. – 2016. – vol. 152, no. 3, pp. 291–298.
  7. 7. Kelleher F.C. Targeting NRAS in melanoma / F.C. Kelleher, G.A. McArthur // Cancer Journal. – 2012. – 18 (2). – Р. 132–6.
  8. 8. Mackiewicz-Wysocka М. Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population / М. Mackiewicz-Wysocka, Małgorzata [et al.] // Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. – 2017. – V. 34 (5) – P. 490–498.
  9. 9. Mohammadpour A. Melanoma: where we are and where we go / A. Mohammadpour, M. Derakhshan, H. Darabi [et al.] // Journal of Cellular Physiology. – 2019. – V. 234 (4). – P. 3307–3320. – DOI 10.1002/jcp.27286. – EDN BRXCCX
  10. 10. Malladi N.S.N. A descriptive observational study on clinical and dermoscopic features of benign melanocytic neoplasms / NSN Malladi, SB Chikhalkar [et al.] // Indian J Dermatol Venereol Leprol. – 2020. – 86 (3). – Р. 251–261.
  11. 11. Pratama A.Y. Description and Histopathology Type of Pigmentosus Nevus in Dustira Hospital and Cibabat Hospital Cimahi / A.Y. Pratama // Conference: 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on «Emergency Preparedness and Dis-aster Response during COVID 19 Pandemic». – 2021. – vol. 37. – Р. 193–196.
  12. 12. Schadendorf D. Melanoma / D. Schadendorf, A.C.J. van Akkooi, C. Berking [et al.] // The Lancet. – 2018. – vol. 392, no. 10151. – pp. 971–984. – DOI 10.1016/S0140-6736(18)31559-9. – EDN YKDORF
  13. 13. Shain A.H. The genetic evolution of melanoma from precursor lesions / A.H. Shain, I. Yeh, I. Kovalyshyn [et al.] // The New England Journal of Medicine. – 2015. – vol. 373, no. 20. – pp. 1926–1936.
  14. 14. Shain A.H. From melanocytes to melanomas / A.H. Shain, B.C. Bastian // Nature reviews Cancer. – 2016. – 16. – Р. 345–58.
  15. 15. Shitara D. Mutational status of naevus-associated melanomas / D. Shitara, G. Tell-Marti, C. Badenas [et al.] // Br. J. Dermatol. – 2015. – 173 (3). – Р. 671–680.
  16. 16. Shitara D. Nevus-associated melanomas: clinicopathologic features / D Shitara, MM Nascimento, S Puig [et al.] //Am J Clin Pathol. – 2014. – 142. – Р. 485–491.
  17. 17. Siegel R.L. Cancer statistics / R.L. Siegel, K.D. Miller, A. Jemal // Cancer Journal for Clinicians – 2020. – vol. 70, no. 1, pp. 7–30.
  18. 18. Tan J.M. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation / J.M. Tan, L.N. Tom, K. Jagirdar [et al.] // British Journal of Dermatology. – 2018. – 178. – Р. 191–7.
  19. 19. Wei Han. Identification, Validation, and Functional Annotations of Genome-Wide Profile Variation between Melanocytic Nevus and Malignant Melanoma / Wei Han, W.-H. Xu, J.-X. Wang et al. // BioMed Research International. – 2020. – 1840415.
  20. 20. Whiteman D.C. Melanocytic nevi, solar keratoses, and divergent path-ways to cutaneous melanoma / D.C. Whiteman [et al.] // Journal of the National Cancer Institute. – 2003. – 95. – Р. 806–812. – EDN ISMFFB
  21. 21. Yeh I. Bastian Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia / I. Yeh, B.C. von Deimling // Journal of the National Cancer Institute. – 2013. – 105. – Р. 917–919.

Comments(0)

When adding a comment stipulate:
  • the relevance of the published material;
  • general estimation (originality and relevance of the topic, completeness, depth, comprehensiveness of topic disclosure, consistency, coherence, evidence, structural ordering, nature and the accuracy of the examples, illustrative material, the credibility of the conclusions;
  • disadvantages, shortcomings;
  • questions and wishes to author.